|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2017-08-29 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2014-08-06 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2011-01-01 |
Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients - ARTEMISIA Study
Open-label, inteRventional clinical Trial to assess EffIcacy and safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients.
Open-label, multicenter, multinational, interventional Clinical Trial to assess Efficacy and Safety of the extemporaneous combination of Nebivolol and Ramipril in hypertensive patients - ARTEMISIA study - ARTEMISIA study
Open-label, multicenter, multinational, interventional Clinical Trial to assess Efficacy and Safety of the extemporaneous combination of Nebivolol and Ramipril in hypertensive patients - ARTEMISIA study - ARTEMISIA study
100 项与 Menarini International Operations Luxembourg SA 相关的临床结果
0 项与 Menarini International Operations Luxembourg SA 相关的专利(医药)
100 项与 Menarini International Operations Luxembourg SA 相关的药物交易
100 项与 Menarini International Operations Luxembourg SA 相关的转化医学